DPP4 reduces proinflammatory cytokine production in human rheumatoid arthritis synovial fibroblasts

Chien Kuo Han, Wei Fang Lee, Chin Jung Hsu, Yuan Li Huang, Chih Yang Lin, Chun Hao Tsai, Chien Chung Huang, Yi Chin Fong, Min Huan Wu, Ju Fang Liu, Chih Hsin Tang

研究成果: 雜誌貢獻文章同行評審

1 引文 斯高帕斯(Scopus)

摘要

Rheumatoid arthritis (RA) is an autoimmune disorder that is characterized by increasing levels of proinflammatory cytokines. The ubiquitous enzyme dipeptidyl peptidase-4 (DPP4, also known as CD26) regulates different immune disorders, although the effects of DPP4 in RA are uncertain. Here, we found lower levels of DPP4 in RA synovial tissues compared with normal tissues. DPP4 levels were also lower in a rat collagen-induced arthritis model than in control (healthy) rats. Overexpression of DPP4 or exogenous treatment of RA synovial fibroblasts with DPP4 reduced levels of proinflammatory interleukin (IL)-1β, IL-6, and IL-13, and increased anti-inflammatory IL-10 synthesis, while DPP4 inhibitors sitagliptin and vildagliptin increased proinflammatory cytokine production, indicating an enhanced risk of RA development. The evidence suggests that increasing DPP4 expression is a novel strategy for RA disease.

原文英語
頁(從 - 到)8060-8069
頁數10
期刊Journal of Cellular Physiology
236
發行號12
DOIs
出版狀態已發佈 - 12月 2021

ASJC Scopus subject areas

  • 生理學
  • 臨床生物化學
  • 細胞生物學

指紋

深入研究「DPP4 reduces proinflammatory cytokine production in human rheumatoid arthritis synovial fibroblasts」主題。共同形成了獨特的指紋。

引用此